Bacterial Infection: Clinical Trials

6 trials for Bacterial Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Terminated 1, Unknown 1

Follow Bacterial Infection: new trials by email Literature Review of Bacterial Infection trials Research Report on Bacterial Infection

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer
Chlorhexidine, NaCl 0.9 % - Bacterial Infection
Phase 3CompletedRennes University Hospital802016-05-232018-12-20
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Chlorhexidine Gluconate Skin Cleanser, Laboratory Biomarker Analysis, Mild Soap Skin Cleanser - Bacterial Infection, Benign Neoplasm
Phase 3CompletedChildren's Oncology Group1772013-11-042021-06-22
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
levofloxacin - Acute Leukemias of Ambiguous Lineage, Bacterial Infection
Phase 3CompletedChildren's Oncology Group6242011-09-012020-12-07
Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
Meropenem, Standard antibiotic therapy - Bacterial Infection
Phase 3TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)4602006-10-012013-06-07
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
ceftriaxone, procaine penicillin and gentamicin, oral cotrimoxazole and gentamicin - Bacterial Infection, Sepsis
Phase 3UnknownAga Khan University4262003-11-012006-09-11
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
tobramycin - Cystic Fibrosis, Bacterial Infection
Phase 3CompletedFDA Office of Orphan Products Development2001995-06-012015-03-25

Narrower conditions

Bacterial Infections (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Communicable Diseases (1)  ·  Cystic Fibrosis (1)  ·  Diarrhea (1)  ·  Genetic Diseases, Inborn (1)  ·  Head and Neck Neoplasms (1)  ·  Immune System Diseases (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Mycoses (1)  ·  Neonatal Sepsis (1)  ·  Neoplasms (1)  ·  Neutropenia (1)  ·  Rare Diseases (1)  ·  Respiratory Tract Diseases (1)

Broader conditions

Bacterial Infections and Mycoses (6)  ·  Infections (6)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Infant, Newborn, Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)

Interventions

Ceftriaxone (1)  ·  Chlorhexidine (1)  ·  Gentamicins (1)  ·  Levofloxacin (1)  ·  Meropenem (1)  ·  Penicillin G Procaine (1)  ·  Tobramycin (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  chlorhexidine gluconate (1)

Sponsors

Children's Oncology Group (2)  ·  Aga Khan University (1)  ·  FDA Office of Orphan Products Development (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Rennes University Hospital (1)

Countries

United States (3)  ·  Canada (2)  ·  France (1)  ·  Pakistan (1)  ·  Puerto Rico (1)

Top investigators

Alan Bruce Montgomery (1)  ·  Anita KM Zaidi, MBBS, SM (1)  ·  Danielle M Zerr (1)  ·  Sarah Alexander, MD (1)

NIH funding

U10CA095861 (2), R01CA163394 (1), UG1CA189955 (1)